Teva Pharmaceutical Industries
- Market cap
- 45.70B
- P/E (TTM)i
- 65.30
- P/Bi
- 5.89
- EPSi
- 1.21
- Div yieldi
- 0.00%
- 52W posi
- 93%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Teva Pharmaceutical Industries closed at 39.18, up 0.13%. The company carries a market value of roughly 45.70B, the #471 most valuable US-listed company we track. The 4 analysts covering the stock are, on balance, at Buy, targeting an average of 45.00 (+15%). Over the past year the stock has ranged from 18.83 to 40.79; it now sits 93% up that band.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 7% of the universe, above its 200-day average.
- Signal has read BUY for 2 months.
- Its last 4 Buy calls have averaged +15% over the following quarter.
- Recent price momentum is +54.1% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 977 U.S. stocks StockVane covers.
Valuation D+
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 66.1x | Better than 9% |
| Forward P/E | 25.6x | Better than 28% |
| Price / Sales | 2.7x | Better than 54% |
| P/E vs own 5-yr range | 100th pctl | Better than 0% |
Growth C-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | 5.0% | Better than 43% |
| Net income CAGR (3Y) | -36.2% | Better than 7% |
| Free cash flow CAGR (3Y) | 3.3% | Better than 39% |
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 51.8% | Better than 65% |
| Operating margin | 22.9% | Better than 72% |
| Net margin | 8.2% | Better than 39% |
| Return on equity | 21.2% | Better than 69% |
| Return on invested capital | 8.7% | Better than 49% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 14.5% | Better than 82% |
| 6-month return | 35.2% | Better than 83% |
| 12-month return (ex latest month) | 82.2% | Better than 91% |
| Distance below 52-week high | 2.8% | Better than 95% |
Financial Health D
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 1.0x | Better than 27% |
| Debt to assets | 42.0% | Better than 36% |
| Interest coverage | 2.3x | Better than 22% |
| Free cash flow / net income | 81.4% | Better than 27% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 80% |
| Upside to average target | 13.5% | Better than 24% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector, so capital-light software tends to grade lower there than utilities. Recomputed every 6 hours from our market data. Not investment advice, and not tailored to your financial situation, goals, or risk tolerance.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 39.13
- Open
- 38.93
- Day range
- 38.65 - 39.39
- Avg price
- 39.08
- Volume
- 3.46M
- Turnover
- 135.04M
- Turnover ratei
- 0.32%
- Volume ratioi
- 0.64
- Amplitudei
- 1.90%
- 52-week rangei
- 18.83 - 40.79
Valuation
- P/Ei
- 32.38
- P/E (TTM)i
- 65.30
- P/Bi
- 5.89
- EPSi
- 1.21
- Book value / shi
- 6.65
- Net profit
- 1.41B
- Net assets
- 7.75B
Share structure
- Market cap
- 45.70B
- Float capi
- 42.69B
- Shares out
- 1.17B
- Float sharesi
- 1.09B
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
3.9% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-114.17M net over the window
Short interest
- Shares short
- 31.48M
- % of floati
- 2.70%
- Days to coveri
- 27.35
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Teva Pharmaceutical Industries (TEVA)?
Teva Pharmaceutical Industries last traded at 39.18. The quote on this page refreshes every few seconds while US markets are open.
What is Teva Pharmaceutical Industries's market cap?
About 45.70B.
What is the P/E ratio of Teva Pharmaceutical Industries?
The trailing twelve-month P/E is 65.30. The Valuation tab shows it against the stock's own five-year range.
Does Teva Pharmaceutical Industries pay a dividend?
Teva Pharmaceutical Industries does not currently pay a regular dividend.
Is Teva Pharmaceutical Industries a buy according to analysts?
The consensus of 4 analysts is a Buy rating, with an average 12-month price target of 45.00, which implies 14.9% upside from the current price. This is not investment advice.
What is Teva Pharmaceutical Industries's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Teva Pharmaceutical Industries a B (Buy). Twelve-month momentum in the top 7% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-08 06:39:28 · For reference only, not investment advice and not tailored to your situation.